Your browser doesn't support javascript.
loading
Patient sexuality disclosure experience and associations with clinical sexual health outcomes among HIV-negative men who have sex with men in Mexico.
Algarin, Angel B; Wiginton, John Mark; Sanchez, Travis H; Hernandez-Avila, Mauricio; Baruch-Dominguez, Ricardo; Smith, Laramie R.
Afiliación
  • Algarin AB; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA. Electronic address: aalgarin@health.ucsd.edu.
  • Wiginton JM; Department of Health, Behavior and Society, Johns Hopkins University, Baltimore, MD, USA. Electronic address: jwigint2@jhmi.edu.
  • Sanchez TH; Department of Epidemiology, Rollins School of Public Health, Atlanta, GA, USA. Electronic address: travis.sanchez@emory.edu.
  • Hernandez-Avila M; Dirección de Presentaciones Económicas y Sociales, Instituto Mexicano del Seguro Social, Av. Reforma 476, col. Juárez, 06600 Cuauhtémoc, Ciudad de México, Mexico. Electronic address: mauricio.hernandeza@imss.gob.mx.
  • Baruch-Dominguez R; International Planned Parenthood Federation, Western Hemisphere Region, Mexico City, MX, Mexico. Electronic address: rbaruch@ippfwhr.org.
  • Smith LR; Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA. Electronic address: laramie@health.ucsd.edu.
Prev Med ; 163: 107225, 2022 10.
Article en En | MEDLINE | ID: mdl-36029923
ABSTRACT
Many men who have sex with men (MSM) do not disclose their sexuality to their healthcare provider, despite potential health benefits. Data from the 2017 Encuesta de Sexo Entre Hombres online survey of 13,277 HIV-negative or unknown status MSM in Mexico were used to explore MSM patients' sexuality disclosure experience on sexual health outcomes using multivariable Poisson models with robust variance estimation to estimate adjusted prevalence ratios (aPR). Sexual health outcomes included Hepatitis B (HepB) and human papillomavirus (HPV) vaccination, and lifetime and past year HIV testing. Overall, 53.9% (n/N) disclosed their sexuality to their healthcare provider, and of those 6.4%, 62.9%, and 30.7% reported a negative, neutral, or positive disclosure experience, respectively. In comparison to no disclosure, neutral and positive disclosure experiences were associated with HepB vaccination (aPR[95% Confidence Interval (95% CI)] = 1.17[1.09, 1.25], p < 0.001; aPR[95% CI] = 1.35[1.25, 1.46], p < 0.001, respectively) and positive disclosure experiences were associated with HPV vaccination (aPR[95% CI] = 1.46[1.24, 1.71], p < 0.001). Those who disclosed their sexual behavior were more likely than those who did not disclose their sexual behavior to have received an HIV test in their lifetime (negative aPR[95% CI] = 1.51[1.43, 1.60], p < 0.001; neutral aPR[95% CI] = 1.61[1.56, 1.66], p < 0.001; positive aPR[95% CI] = 1.64[1.58, 1.69], p < 0.001) and an HIV test in the past year (negative aPR[95% CI] = 1.89[1.70, 2.10], p < 0.001; neutral aPR[95% CI] = 2.09[1.98, 2.20], p < 0.001; positive aPR[95% CI] = 2.24[2.12, 2.37], p < 0.001). There is a need to implement trainings for healthcare providers that focus on sexual health risk assessments and creating a space that encourages MSM patients and healthcare providers to discuss sexual health.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Infecciones por Papillomavirus / Minorías Sexuales y de Género Tipo de estudio: Risk_factors_studies Límite: Humans / Male País/Región como asunto: Mexico Idioma: En Revista: Prev Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Infecciones por Papillomavirus / Minorías Sexuales y de Género Tipo de estudio: Risk_factors_studies Límite: Humans / Male País/Región como asunto: Mexico Idioma: En Revista: Prev Med Año: 2022 Tipo del documento: Article